13F Insight
DOSSIER · 13F Holders · Q2 2026
AGMB

AgomAb Therapeutics NV ADR

35 institutions still hold AgomAb Therapeutics NV ADR as of Q2 2026. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.

CUSIP 00860C102·35 13F holders·last filed Jun 30, 2026
Market cap
—
13F value held
$316M
visible holders
Holders
35
filers reporting
Concentration
21.13%
EQT Fund Management S.a r.l. #1
top holder share
AI Holders Summary · Q2 2026

35 institutions reported AGMB in Q2 2026. EQT Fund Management S.a r.l. leads at 21.1% of the visible book.

Top holders

Sorted by position value. Source: SEC EDGAR 13F-HR filings.

#HolderValueShares% port.Quarter
01
EQT Fund Management S.a r.l.
CIK 0001834239
$67M5.1M7.74%Q2 202602
Nantahala Capital Management, LLC
CIK 0001472322
$41M3.1M0.68%Q2 202603
Sanofi
CIK 0001121404
$36M2.8M6.76%Q2 202604
Cormorant Asset Management, LP
CIK 0001583977
$32M2.5M1.64%Q2 202605
TCG Crossover Management, LLC
CIK 0001839948
$27M2.1M0.64%Q2 202606
FEDERATED HERMES, INC.
CIK 0001056288
$21M1.6M0.03%Q2 202607
Casdin Capital, LLC
CIK 0001534261
$20M1.6M1.01%Q2 202608
FMR LLC
CIK 0000315066
$19M1.5M0.00%Q2 202609
Andera Partners
CIK 0001757283
$17M1.5M9.72%Q3 202610
Aberdeen Group plc
CIK 0001716774
$11M847K0.02%Q2 202611
PERCEPTIVE ADVISORS LLC
CIK 0001224962
$6M600K0.12%Q1 202612
Samsara BioCapital, LLC
CIK 0001744967
$6M600K0.61%Q1 202613
Siren, L.L.C.
CIK 0002005245
$5M411K0.11%Q2 202614
ORBIMED ADVISORS LLC
CIK 0001055951
$3M193K0.05%Q2 202615
Redmile Group, LLC
CIK 0001425738
$2M156K0.11%Q1 202616
PFIZER INC
CIK 0000078003
$1M75K0.61%Q2 202617
ALPS ADVISORS INC
CIK 0001376113
$649K50K0.00%Q2 202618
Bellevue Group AG
CIK 0001674546
$639K49K0.01%Q2 202619
SEVEN GRAND MANAGERS, LLC
CIK 0001909126
$618K48K0.02%Q2 202620
SECTORAL ASSET MANAGEMENT INC
CIK 0001274413
$565K44K0.39%Q2 2026
Page 1 of 2
15 more holders available. Log in →
Insiders at AgomAb Therapeutics NV ADR
Epstein David R →Kemula Pierre Thadee Victor →Knotnerus Tim Jasper →Patel Naimish →Garcia Marino →